BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24372084)

  • 1. Heterozygous frameshift mutation in keratin 5 in a family with Galli-Galli disease.
    Reisenauer AK; Wordingham SV; York J; Kokkonen EW; Mclean WH; Wilson NJ; Smith FJ
    Br J Dermatol; 2014 Jun; 170(6):1362-5. PubMed ID: 24372084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dowling-Degos Disease in the Anogenital Region.
    Belamarić M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):261-262. PubMed ID: 36919394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expanding spectrum of Galli-Galli disease.
    El Shabrawi-Caelen L; Rütten A; Kerl H
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S86-91. PubMed ID: 17434047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galli-Galli Disease Presenting as a Lentigo-like Eruption: A Further Clinical Feature in the Wide Spectrum of Reticulate Pigment Disorders.
    Paolino G; Donati M; Didona D; Panetta C; Donati P
    Acta Dermatovenerol Croat; 2017 Dec; 25(4):300-302. PubMed ID: 30064605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease.
    Hanneken S; Rütten A; Pasternack SM; Eigelshoven S; El Shabrawi-Caelen L; Wenzel J; Braun-Falco M; Ruzicka T; Nöthen MM; Kruse R; Betz RC
    Br J Dermatol; 2010 Jul; 163(1):197-200. PubMed ID: 20222933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heterozygous frameshift mutation in the V1 domain of keratin 5 in a family with Dowling-Degos disease.
    Liao H; Zhao Y; Baty DU; McGrath JA; Mellerio JE; McLean WH
    J Invest Dermatol; 2007 Feb; 127(2):298-300. PubMed ID: 16917491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.
    Verma S; Pasternack SM; Rütten A; Ruzicka T; Betz RC; Hanneken S
    Indian J Dermatol; 2014 Sep; 59(5):476-80. PubMed ID: 25284854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized Dowling-Degos disease.
    Wu YH; Lin YC
    J Am Acad Dermatol; 2007 Aug; 57(2):327-34. PubMed ID: 17637446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of the role of a KRT5 mutation and successful management of skin lesions in a patient with Galli-Galli disease.
    Lőrincz K; Medvecz M; Kiss N; Glász-Bóna A; Hársing J; Lepesi-Benkő R; Hatvani Z; Mazán M; Kárpáti S; Wikonkál N
    Clin Exp Dermatol; 2018 Dec; 43(8):972-974. PubMed ID: 29882260
    [No Abstract]   [Full Text] [Related]  

  • 10. Galli-Galli Disease: A Comprehensive Literature Review.
    Michelerio A; Greco A; Tomasini D; Tomasini C
    Dermatopathology (Basel); 2024 Feb; 11(1):79-100. PubMed ID: 38390850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients].
    Hanneken S; Rütten A; Eigelshoven S; Braun-Falco M; Pasternack SM; Ruzicka T; Nöthen MM; Betz RC; Kruse R
    Hautarzt; 2011 Nov; 62(11):842-51. PubMed ID: 21971768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galli-Galli disease is an acantholytic variant of Dowling-Degos disease.
    Sprecher E; Indelman M; Khamaysi Z; Lugassy J; Petronius D; Bergman R
    Br J Dermatol; 2007 Mar; 156(3):572-4. PubMed ID: 17300252
    [No Abstract]   [Full Text] [Related]  

  • 13. Galli-Galli disease is an acantholytic variant of Dowling-Degos disease: additional genetic evidence in a German family.
    Schmieder A; Pasternack SM; Krahl D; Betz RC; Leverkus M
    J Am Acad Dermatol; 2012 Jun; 66(6):e250-1. PubMed ID: 22583733
    [No Abstract]   [Full Text] [Related]  

  • 14. Dowling-Degos disease: a review.
    Stephan C; Kurban M; Abbas O
    Int J Dermatol; 2021 Aug; 60(8):944-950. PubMed ID: 33368260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel heterozygous nonsense mutation of keratin 5 in a Chinese family with Dowling-Degos disease.
    Guo L; Luo X; Zhao A; Huang H; Wei Z; Chen L; Qin S; Shao L; Xuan J; Feng G; Minghua C; Luan J; He L; Xing Q
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):908-10. PubMed ID: 21569119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Disseminated Variant of Galli-Galli Disease: A Review of the Literature.
    Yang A; Cheung K; Kossard S; Murrell DF
    Am J Dermatopathol; 2020 Jul; 42(7):484-490. PubMed ID: 31449063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dowling-Degos disease co-presenting with Darier disease.
    Strausburg M; Linos K; Staser K; Mousdicas N
    Clin Exp Dermatol; 2016 Jun; 41(4):410-2. PubMed ID: 26685052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Galli-Galli disease presenting as lichenoid papules in the flexures].
    García-Salces I; Hörndler C; Requena L
    Actas Dermosifiliogr; 2010 Mar; 101(2):168-72. PubMed ID: 20223160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis Suppurativa Associated with Galli-Galli Disease: Extending the Link with Dowling-Degos Disease.
    Del Mar M; González M; Sayed C; Phadke P
    J Clin Aesthet Dermatol; 2020 Dec; 13(12):38-40. PubMed ID: 33488918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dowling-Degos disease involving the vulva and back: case report and review of the literature.
    Horner ME; Parkinson KE; Kaye V; Lynch PJ
    Dermatol Online J; 2011 Jul; 17(7):1. PubMed ID: 21810386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.